Funko Inc vs Novartis AG — how do they compare? Funko Inc trades at $6.2 (market cap $332.33M), while Novartis AG trades at $152.33 (market cap $295.37B). The key difference: Novartis AG is far larger — about 888.8× Funko Inc's market cap, and Novartis AG pays a 3.07% dividend while Funko Inc pays none. Which is the better fit depends on your goals.
| FNKO | NVS | |
|---|---|---|
Market Cap | $332.33M | $295.37B |
Sector | Consumer Staples | Health |
52-Week High | $6.35 | $168.62 |
52-Week Low | $2.65 | $119.31 |
Enterprise Value | $552.98M | $336.69B |
Dividend Yield | — | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
Funko Inc is a US-based pop culture consumer products company. It creates whimsical, fun, and different products which enable the customer to express their affinity for their favorite through movie, TV show, video game, musician or sports team. The company holds licenses and the rights to create tens of thousands of characters including Game of Thrones, Walking Dead, Disney, Marvel, Harry Potter, Fallout, and others. Its products include Pop, Dorbz, Mystery Vinyl, Plush, Action Figures, and Others. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites.
Read more on FNKO →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →